A Single Intravenous Dose Study of E3112 in Japanese Healthy Adult Male Subjects

Clinical trial NCT03014895 · COMPLETED

Trial details

NCT number: NCT03014895
Sponsor: EA Pharma Co., Ltd.
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Healthy Male Volunteers

Start date: 2017-01-25
Primary completion: 2017-06-12
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.